Viewing Study NCT00881205

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2025-12-26 @ 2:11 AM
Study NCT ID: NCT00881205
Status: TERMINATED
Last Update Posted: 2012-03-12
First Post: 2009-04-14
Is NOT Gene Therapy: False
Has Adverse Events: True
Brief Title: Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
None Cognitive Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Sclerosis View
None Cognition View
None Rivastigmine View
None Patch View